Beth Israel Deaconess Medical Center Awarded $11.5 Million To Research Kidney Cancer
The National Cancer Institute (NCI) has awarded Beth Israel Deaconess Medical Center (BIDMC) an $11.5 million, fiveyear SPORE grant to focus on cancers of the kidney. Michael Atkins, MD, Deputy Director of BIDMCs Division of Hematology/Oncology, will oversee the grant, which involves collaborations with Brigham and Womens Hospital, DanaFarber Cancer Institute, and Massachusetts General Hospital [...]